French biotech company Ipsen to buy Kartos Therapeutics for $450 million
Ipsen will buy U.S.-based Kartos Therapeutics for $450 million to expand its oncology pipeline with a late-stage blood cancer treatment, the French biotech company said on Monday.
June 29, 2026
Brazil's Bolsonaro to remain under house arrest
Fallout from Venezuela's earthquakes turns political as opposition leader Machado seeks return
Conservative candidate Keiko Fujimori wins Peru’s presidential election in a runoff
Russian defence ministry says its forces captured Kostiantynivka in eastern Ukraine
Largest US power grid PJM orders emergency curbs as electricity use nears record peak
US striker Folarin Balogun says a yellow card, not red card, would have been ‘fair’ at the World Cup
Trump administration’s interpretation of slavery under George Washington can be reinstalled
Flyers sign Ducks center Carlsson to 5-year, $90 million offer sheet; Anaheim has 7 days to match